Results 141 to 150 of about 23,074,058 (199)

Disproportionality analysis of drug-induced myocarditis: Insights from the Food and Drug Administration Adverse Event Reporting System database. [PDF]

J Int Med Res
Pang J, Zhu W, Zhang Y, Guo W.
europepmc   +1 more source

Autoimmune Reporting Signals in FAERS Reports Listing COVID-19 Vaccines as Suspect Products: An Active-Comparator Disproportionality Analysis. [PDF]

Int J Environ Res Public Health
Messova AM, Sanbayev M, Abdrahmanova ST, Temirkhanova R, Mussin NM, Tamadon A.   +5 more
europepmc   +1 more source

Correction: Comparative safety profile of biktarvy: insights from a clinical cohort and the FAERS database

Frontiers in Pharmacology
Xinmei Pan, Qingqing Tian, Qian Wang, Linli Xie, Jiangchuan Xie   +4 more
doaj   +1 more source

Hepatic Safety Profile of Atomoxetine and Methylphenidate in Patients with ADHD: Disproportionality Analysis Using EudraVigilance Database Data. [PDF]

Pharmaceuticals (Basel)
Di Napoli R, Laino LV, Rafaniello C, Di Costanzo L, Sullo MG, Scavone C, Capuano A.   +6 more
europepmc   +1 more source

Neurological Adverse Events Associated With Immune Checkpoint Inhibitors Identified Through Disproportionality Analysis of the FDA Adverse Event Reporting System. [PDF]

Cancer Med
Chen T, Shu K, Xiao H, Yuan Y, Zhang F, Liu Y.   +5 more
europepmc   +1 more source

Ocrelizumab-induced colitis: VigiBase disproportionality analysis, case reports and literature review. [PDF]

Br J Clin Pharmacol
Fresse A, Hommel C, Petitpain N, Kerschen P.   +3 more
europepmc   +1 more source

Post-marketing safety surveillance of tetanus, diphtheria, and acellular pertussis (Tdap) vaccine: a disproportionality analysis of the vaccine adverse event reporting system (2015-2025). [PDF]

Front Cell Infect Microbiol
Song W, Chen H, Wang M, Liang Z.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

The evolving role of disproportionality analysis in pharmacovigilance

Expert Opinion on Drug Safety
From 2009 to 2015, the IMI PROTECT conducted rigorous studies addressing questions about optimal implementation and significance of disproportionality analyses, leading to the development of Good Signal Detection Practices. The ensuing period witnessed the independent exploration of research paths proposed by IMI PROTECT, accumulating valuable ...
Manfred Hauben, Elisabetta Poluzzi, Emanuel Raschi   +2 more
exaly   +4 more sources